APA (7th ed.) Citation

A, W., H, A., C, H., S, Y., C, L., CJD, R., & BC, C. (2023). Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia. Frontiers in pharmacology, 14, 1257745. https://doi.org/10.3389/fphar.2023.1257745

Chicago Style (17th ed.) Citation

A, Wu, Anderson H, Hughesman C, Young S, Lohrisch C, Ross CJD, and Carleton BC. "Implementation of Pharmacogenetic Testing in Oncology: DPYD-guided Dosing to Prevent Fluoropyrimidine Toxicity in British Columbia." Frontiers in Pharmacology 14 (2023): 1257745. https://doi.org/10.3389/fphar.2023.1257745.

MLA (9th ed.) Citation

A, Wu, et al. "Implementation of Pharmacogenetic Testing in Oncology: DPYD-guided Dosing to Prevent Fluoropyrimidine Toxicity in British Columbia." Frontiers in Pharmacology, vol. 14, 2023, p. 1257745, https://doi.org/10.3389/fphar.2023.1257745.